It could be that mutations effecting FOXF1 or FENDRR could reduce ACTA2 activity resulting in cellular dysfunction akin to that seen in Multisystemic Smooth Muscle Dysfunction Syndrome. This evidence concerns the gene FOXF1 and multisystemic smooth muscle dysfunction syndrome.